Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

A Beginner’s Guide to Low-Dose Social Drinking

Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…

2 days ago

6 Surprising Truths Cannabis Actually Teaches You About Yourself

A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…

3 days ago

DEA Hearing Bombshell: Marijuana Rescheduling Rules Never Existed

Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…

4 days ago

Why Trump Lost the 2026 Midterms: The 2028 Cannabis & Hemp Playbook

Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…

5 days ago

Dr. Siegel’s Marijuana Math Doesn’t Add Up: Why the Data on Parents, Teens, and Cannabis Tells a Different Story

On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…

1 week ago

The Truth About Medical Marijuana: Why Cannabis Is Neither a Miracle Nor a Menace

Is cannabis a miracle cure or a gateway to ruin? We break down the latest…

1 week ago